URTICARIA (HIVES)

 

URTICARIA (HIVES)

 

DEFINITION:

An inflammatory disorder within the skin often initiated by an IgE-mediated hypersensitivity.

EPIDEMIOLOGY:

  • incidence: 10% of children
  • age of onset:
    • any
  • risk factors:
    • see below
    • F > M

PATHOGENESIS:

1. Allergy

1. Background

  • allergy is the manifestation of a hypersensitivity reaction to the presentation of an allergen due to the propensity of the affected individual to develop a sustained IgE response following antigenic stimulation
  • the distinguishing feature of the allergic individual is the propensity to develop a sustained IgE response
  • there are several types of allergies based upon where the hypersensitive reaction occurs:

Surface - Allergy

  • Nasal Mucosa - Allergic Rhinitis
  • Skin - Hives (Urticaria), Atopic Dermatitis
  • Respiratory Tract - Allergic Asthma
  • Systemic - Anaphylaxis

2. Allergens

  • allergens are compounds capable of inducing human IgE antibody formation ("sensitization")

3. IgE

  • IgE is a Homocytotropic Antibody: an antibody capable of interacting with target cells such that these cells release mediators on contact with specific antigens
  • the IgE receptor consists of an externally located alpha chain that binds the IgE and is noncovalently associated with a beta chain and two gamma chains
  • there are two categories of IgE receptors dependent upon the type of cells targetted and the type of mediators released from these cells:

1. Type 1

  • target cells - mast cells, basophils
  • affinity - high affinity for IgE
  • mediators - histamine, ECF-A, leukotrienes, bradykinins, prostaglandins, PAF, anaphylatoxins

2. Type 2

  • target cells - lymphocytes, platelets, eosino-phils, monocytes-macrophages
  • affinity - low affinity for IgE
  • mediators - chemotaxic factors, IgE binding factors (T cells), mitogens (B cells), inflammatory mediators

2. IgE-Mediated Urticaria

1. Background

  • an allergy specific to the skin in susceptible individuals

2. Allergens

1. Infections

  • bacterial, viral (hepatitis, infectious mononucleosis) fungal, parasitic

2. Drugs

  • penicillin, sulfa drugs, phenytoin, barbiturates, ASA

3. Foods

  • nuts, shellfish or seafood, chocolate, dairy products (milk, eggs)

3. IgE

  • within the superficial layers of the epidermis of the skin a Type 1 homocytotropic antibody response occurs
  • mast cells, basophils are the target cells
  • mediator response:
    • release of histamine -> intensely pruritic response associated with hives
    • also stimulates the axon reflex -> wheal and flare reaction

3. Non-IgE Mediated Urticaria

1. Background

  • non-immunologic events cause degranulation of mast cells resulting in the release of histamine within the superficial layers of the epidermis of the skin

2. Triggers

1. Drugs

  • codeine, curare derivatives, morphine

2. Physical Agents

  • cold, local heat, pressure (dermatographism), solar, exercise-induced

3. Arachidonic Pathway Activators

  • aspirin, food dyes (azo dyes, benzoates, tartrazine), preservatives (metabisulfite, methylparabens, benzoic acid)

4. Complement-Induced

1. Diseases
  • cancer (leukemia, lymphoma)
  • collagen vascular disease (rheumatoid arthritis, SLE, cryoglobulinemia, Sjogren Syndrome)
  • Hereditary Angioedema, hyperthyroidism
2. Others
  • blood transfusions, radiocontrast dyes

5. Others

  • Cholinergic Urticaria
  • Familial Cold Urticaria
  • crustacean secretions, snake venoms

CLINICAL FEATURES:

1. Cutaneous Manifestations

1. Urticaria

  • erythematous raised skin lesion (wheal)
    • localized or generalized
    • well circumscribed but sometimes coalescent
    • may be intensely pruritic
    • most common over bony prominences
    • vary in size from tiny flat papules to large raised plaques
    • flat centre with raised erythematous edge
    • diagnostic feature is transience of individual lesions
      • small individual lesions usually last from 24-48 hours but new lesions may continue to appear singly or in crops
      • large lesions may last longer but tend to change shape
  • types:
    • 1. Acute - urticaria lasts less than 6 weeks
    • 2. Chronic - urticaria lasts greater than 6 weeks

2. Angioedema

  • similar skin lesion as urticaria but involves the deeper layers of the dermis and submucosal or subcutaneous tissues
  • may also involve:
    • upper airway - with stridor +/- obstruction
    • gastrointestinal tract

INVESTIGATIONS:

1. Allergy Testing

  • may be indicated if history suggests an allergen-induced etiology

MANAGEMENT:

1. Supportive

  • ensure patency of upper airway and patient is hemodynamically-stable

2. Antihistamines

1. Benadryl (Diphenhydramine HCl)

  • 2.5 cc po q4-6h (< 2 years of age)
  • 5.0 cc po q4-6h (2-6 years of age)
  • 10-20 cc po q4-6h (> 6 years of age)

2. Atarax (Hydroxyzine HCl)

  • drug of choice in chronic and cholinergic urticaria

3. Systemic Corticosteroids

  • indicated in severe, acute urticaria and angioedema
  • Prednisone 1-2 mg/kg/day

 

 

Pediatric Database - URTICARIA (HIVES)

Pediatric Organization - Pedbase [at] Gmail.com